{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:55:09Z","timestamp":1772150109436,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T00:00:00Z","timestamp":1332115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T00:00:00Z","timestamp":1332115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                        <jats:title>Introduction\n<\/jats:title>\n                        <jats:p>Remission is an important goal of therapy in rheumatoid arthritis (RA), but data on duration of remission are lacking. Our objective was to describe the duration of remission in RA, assessed by different criteria.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods\n<\/jats:title>\n                        <jats:p>We evaluated patients from the Brigham and Women's Rheumatoid Arthritis Sequential Study (BRASS) not in remission at baseline with at least 2 years of follow-up. Remission was assessed according to the Disease Activity Score 28-C-reactive protein (DAS28-CRP4), Simplified Disease Activity Index (SDAI), and Clinical Disease Activity Index (CDAI) scores, and the recently proposed American College of Rheumatology (ACR)\/European League against Rheumatism (EULAR) criteria for remission. Analyses were performed by using Kaplan-Meier survival curves.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results\n<\/jats:title>\n                        <jats:p>We identified 871 subjects with \u22652 years of follow-up. Of these subjects, 394 were in remission at one or more time-points and not in remission at baseline, according to at least one of the following criteria: DAS28-CRP &lt; 2.6 (<jats:italic>n<\/jats:italic> = 309), DAS28-CRP &lt; 2.3 (<jats:italic>n<\/jats:italic> = 275), SDAI (<jats:italic>n<\/jats:italic> = 168), CDAI (<jats:italic>n<\/jats:italic> = 170), and 2010 ACR\/EULAR (<jats:italic>n<\/jats:italic> = 158). The median age for the 394 subjects at entrance to BRASS was 56 years; median disease duration was 8 years; 81% were female patients; and 72% were seropositive. Survival analysis performed separately for each remission criterion demonstrated that &lt; 50% of subjects remained in remission 1 year later. Median remission survival time was 1 year. Kaplan-Meier curves of the various remission criteria did not significantly differ (<jats:italic>P<\/jats:italic> = 0.29 according to the log-rank test).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions\n<\/jats:title>\n                        <jats:p>This study shows that in clinical practice, a minority of RA patients are in sustained remission.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3785","type":"journal-article","created":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T13:14:38Z","timestamp":1332162878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Sustained rheumatoid arthritis remission is uncommon in clinical practice"],"prefix":"10.1186","volume":"14","author":[{"given":"Femke HM","family":"Prince","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian P","family":"Bykerk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy A","family":"Shadick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Frits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine K","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E","family":"Weinblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,19]]},"reference":[{"key":"3527_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/BOR.0b013e32832a2f02","volume":"21","author":"T Sokka","year":"2009","unstructured":"Sokka T: Long-term outcomes of rheumatoid arthritis. Current Opin Rheumatol. 2009, 21: 284-290. 10.1097\/BOR.0b013e32832a2f02.","journal-title":"Current Opin Rheumatol"},{"key":"3527_CR2","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, et al: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010, 69: 964-975. 10.1136\/ard.2009.126532.","journal-title":"Ann Rheum Dis"},{"key":"3527_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrrheum.2011.63","volume":"7","author":"VP Bykerk","year":"2011","unstructured":"Bykerk VP: Rheumatoid arthritis: 2011 remission criteria are a new benchmark for RA therapy. Nat Rev Rheumatol. 2011, 7: 317-318. 10.1038\/nrrheum.2011.63.","journal-title":"Nat Rev Rheumatol"},{"key":"3527_CR4","doi-asserted-by":"publisher","first-page":"R796","DOI":"10.1186\/ar1740","volume":"7","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, Smolen JS: Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther. 2005, 7: R796-806. 10.1186\/ar1740.","journal-title":"Arthritis Res Ther"},{"key":"3527_CR5","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/art.1780241012","volume":"24","author":"RS Pinals","year":"1981","unstructured":"Pinals RS, Masi AT, Larsen RA: Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 1981, 24: 1308-1315. 10.1002\/art.1780241012.","journal-title":"Arthritis Rheum"},{"key":"3527_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL: Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38: 44-48. 10.1002\/art.1780380107.","journal-title":"Arthritis Rheum"},{"key":"3527_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, van Riel PL, Tugwell P: A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford). 2003, 42: 244-257. 10.1093\/rheumatology\/keg072.","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 10","key":"3527_CR8","first-page":"2108","volume":"62","author":"DT Felson","year":"2010","unstructured":"Felson DT, Smolen J, Wells G, Zhang B, Van Tuyl LH, Funovits J, Aletaha D, Allaart CF: Predictive validity of the new preliminary ACR\/EULAR definitions for remission in rheumatoid arthritis. Arthritis Rheum. 2010, 62 (Suppl 10): 2108-","journal-title":"Arthritis Rheum"},{"key":"3527_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/art.30129","volume":"63","author":"DT Felson","year":"2011","unstructured":"Felson DT, Smolen JS, Wells G, Zhang B, Van Tuyl LH, Funovits J, Aletaha D, Allaart CF, Bathon J, Bombardier S: American College of Rheumatology\/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials. Arthritis Rheum. 2011, 63: 573-586. 10.1002\/art.30129.","journal-title":"Arthritis Rheum"},{"key":"3527_CR10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/art.30199","volume":"63","author":"JR O'Dell","year":"2011","unstructured":"O'Dell JR, Mikuls TR: To improve outcomes we must define and measure them: toward defining remission in rheumatoid arthritis. Arthritis Rheum. 2011, 63: 587-589. 10.1002\/art.30199.","journal-title":"Arthritis Rheum"},{"key":"3527_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/ard.2010.145607","volume":"70","author":"LT Jacobsson","year":"2011","unstructured":"Jacobsson LT, Hetland ML: New remission criteria for RA: \"modern times\" in rheumatology: not a silent film, rather a 3D movie. Ann Rheum Dis. 2011, 70: 401-403. 10.1136\/ard.2010.145607.","journal-title":"Ann Rheum Dis"},{"key":"3527_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/ard.2009.123976","volume":"69","author":"M Schoels","year":"2010","unstructured":"Schoels M, Knevel R, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas DT, Burmester G, Combe B, Cutolo M, Dougados M, Emery P, van der Heijde D, Huizinga TW, Kalden J, Keystone EC, Kvien TK, Martin-Mola E, Montecucco C, de Wit M, Smolen JS: Evidence for treating rheumatoid arthritis to target: results of a systematic literature search. Ann Rheum Dis. 2010, 69: 638-643. 10.1136\/ard.2009.123976.","journal-title":"Ann Rheum Dis"},{"key":"3527_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D, T2T Expert Committee: Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010, 69: 631-637. 10.1136\/ard.2009.123919.","journal-title":"Ann Rheum Dis"},{"key":"3527_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/rheumatology\/keq263","volume":"50","author":"CK Iannaccone","year":"2011","unstructured":"Iannaccone CK, Lee YC, Cui J, Frits ML, Glass RJ, Plenge RM, Solomon DH, Weinblatt ME, Shadick NA: Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Rheumatology (Oxford). 2011, 50: 40-46. 10.1093\/rheumatology\/keq263.","journal-title":"Rheumatology (Oxford)"},{"key":"3527_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/ard.2006.054205","volume":"66","author":"E Inoue","year":"2007","unstructured":"Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N: Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values. Ann Rheum Dis. 2007, 66: 407-409. 10.1136\/ard.2006.054205.","journal-title":"Ann Rheum Dis"},{"key":"3527_CR16","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3899\/jrheum.091333","volume":"37","author":"I Castrejon","year":"2010","unstructured":"Castrejon I, Ortiz AM, Toledano E, Castaneda S, Garcia-Vadillo A, Patino E, Gonzalez-Alvaro I: Estimated cutoff points for the 28-joint disease activity score based on C-reactive protein in a longitudinal register of early arthritis. J Rheumatol. 2010, 37: 1439-1443. 10.3899\/jrheum.091333.","journal-title":"J Rheumatol"},{"key":"3527_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1080\/03009740802484846","volume":"38","author":"P Verschueren","year":"2009","unstructured":"Verschueren P, Esselens G, Westhovens R: Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study. Scand J Rheumatol. 2009, 38: 166-172. 10.1080\/03009740802484846.","journal-title":"Scand J Rheumatol"},{"key":"3527_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/rheumatology\/kep380","volume":"49","author":"A Balsa","year":"2010","unstructured":"Balsa A, Del Amo J, Blanco F, Caliz R, Silva L, Sanmarti R, Martinez FG, Tejedor D, Artieda M, Pascual-Salcedo D, Oreiro N, Collado MD, Andreu JL, Graell E, Sim\u00f3n L, Mart\u00ednez A, Mulero J: Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms. Rheumatology (Oxford). 2010, 49: 458-466. 10.1093\/rheumatology\/kep380.","journal-title":"Rheumatology (Oxford)"},{"key":"3527_CR19","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar3027","volume":"12","author":"LG Schipper","year":"2010","unstructured":"Schipper LG, Fransen J, den Broeder AA, Van Riel PL: Time to achieve remission determines time to be in remission. Arthritis Res Ther. 2010, 12: R97-10.1186\/ar3027.","journal-title":"Arthritis Res Ther"},{"key":"3527_CR20","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1136\/ard.2009.122739","volume":"69","author":"BJ Miriovsky","year":"2010","unstructured":"Miriovsky BJ, Michaud K, Thiele GM, O'Dell JR, Cannon GW, Kerr G, Richards JS, Johnson D, Caplan L, Reimold A, Hooker R, Mikuls TR: Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis. Ann Rheum Dis. 2010, 69: 1292-1297. 10.1136\/ard.2009.122739.","journal-title":"Ann Rheum Dis"},{"key":"3527_CR21","first-page":"85","volume":"27","author":"TE Raghunathan","year":"2001","unstructured":"Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger PA: A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol. 2001, 27: 85-95.","journal-title":"Surv Methodol"},{"key":"3527_CR22","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/rheumatology\/kem007","volume":"46","author":"M Mierau","year":"2007","unstructured":"Mierau M, Schoels M, Gonda G, Fuchs J, Aletaha D, Smolen JS: Assessing remission in clinical practice. Rheumatology (Oxford). 2007, 46: 975-979. 10.1093\/rheumatology\/kem007.","journal-title":"Rheumatology (Oxford)"},{"key":"3527_CR23","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1002\/art.23794","volume":"58","author":"T Sokka","year":"2008","unstructured":"Sokka T, Hetland ML, Makinen H, Kautiainen H, Horslev-Petersen K, Luukkainen RK, Combe B, Badsha H, Drosos AA, Devlin J, Ferraccioli G, Morelli A, Hoekstra M, Majdan M, Sadkiewicz S, Belmonte M, Holmqvist AC, Choy E, Burmester GR, Tunc R, Dimi\u0107 A, Nedovi\u0107 J, Stankovi\u0107 A, Bergman M, Toloza S, Pincus T, Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis Group: Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum. 2008, 58: 2642-2651. 10.1002\/art.23794.","journal-title":"Arthritis Rheum"},{"key":"3527_CR24","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/rheumatology\/kem051","volume":"46","author":"T Sokka","year":"2007","unstructured":"Sokka T, Makinen H, Hannonen P, Pincus T: Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Rheumatology (Oxford). 2007, 46: 1020-1023. 10.1093\/rheumatology\/kem051.","journal-title":"Rheumatology (Oxford)"},{"key":"3527_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/ard.2003.014928","volume":"64","author":"SM Verstappen","year":"2005","unstructured":"Verstappen SM, van Albada-Kuipers GA, Bijlsma JW, Blaauw AA, Schenk Y, Haanen HC, Jacobs JW: A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up. Ann Rheum Dis. 2005, 64: 38-43. 10.1136\/ard.2003.014928.","journal-title":"Ann Rheum Dis"},{"key":"3527_CR26","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1136\/ard.2004.034371","volume":"64","author":"D van der Heijde","year":"2005","unstructured":"van der Heijde D, Klareskog L, Boers M, Landewe R, Codreanu C, Bolosiu HD, Pedersen R, Fatenejad S: Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results. Ann Rheum Dis. 2005, 64: 1582-1587. 10.1136\/ard.2004.034371.","journal-title":"Ann Rheum Dis"},{"key":"3527_CR27","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1002\/art.30524","volume":"63","author":"SH Shahouri","year":"2011","unstructured":"Shahouri SH, Michaud K, Mikuls TR, Caplan L, Shaver TS, Anderson JD, Weidensaul DN, Busch RE, Wang S, Wolfe F: Remission of rheumatoid arthritis in clinical practice: application of the ACR\/EULAR 2011 remission criteria. Arthritis Rheum. 2011, 63: 3204-3215. 10.1002\/art.30524.","journal-title":"Arthritis Rheum"},{"key":"3527_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/art.11481","volume":"50","author":"ET Molenaar","year":"2004","unstructured":"Molenaar ET, Voskuyl AE, Dinant HJ, Bezemer PD, Boers M, Dijkmans BA: Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum. 2004, 50: 36-42. 10.1002\/art.11481.","journal-title":"Arthritis Rheum"},{"key":"3527_CR29","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/rheumatology\/39.7.742","volume":"39","author":"ET Molenaar","year":"2000","unstructured":"Molenaar ET, Lems WF, Dijkmans BA, de Koning MH, van de Stadt RJ, Voskuyl AE: Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis. Rheumatology (Oxford). 2000, 39: 742-744. 10.1093\/rheumatology\/39.7.742.","journal-title":"Rheumatology (Oxford)"},{"key":"3527_CR30","volume-title":"Ann Rheum Dis","author":"S Lillegraven","year":"2011","unstructured":"Lillegraven S, Prince FH, Shadick NA, Bykerk VP, Lu B, Frits ML, Iannaccone CK, Kvien TK, Haavardsholm EA, Weinblatt ME, Solomon DH: Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR\/EULAR remission criteria in an observational cohort. Ann Rheum Dis. 2011"},{"key":"3527_CR31","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nri2804","volume":"10","author":"JD Isaacs","year":"2010","unstructured":"Isaacs JD: The changing face of rheumatoid arthritis: sustained remission for all?. Nat Rev Immunol. 2010, 10: 605-611. 10.1038\/nri2804.","journal-title":"Nat Rev Immunol"},{"key":"3527_CR32","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3899\/jrheum.080560","volume":"36","author":"A Magnani","year":"2009","unstructured":"Magnani A, Pistorio A, Magni-Manzoni S, Falcone A, Lombardini G, Bandeira M, Rossi F, Sala I, Martini A, Ravelli A: Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis. J Rheumatol. 2009, 36: 628-634. 10.3899\/jrheum.080560.","journal-title":"J Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3785.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3785\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3785.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:29:40Z","timestamp":1728383380000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,19]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,4]]}},"alternative-id":["3527"],"URL":"https:\/\/doi.org\/10.1186\/ar3785","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,19]]},"assertion":[{"value":"11 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R68"}}